期刊文献+

人肝星形细胞胰高血糖素样肽1受体的表达 被引量:3

The expression of glucagon-like peptide 1 receptor in human hepatic stellate cell
原文传递
导出
摘要 目的证实胰高血糖素样肽1(GLP_1)受体在人肝星形细胞上的表达。方法体外培养人肝星形细胞并进行形态学鉴定。提取肝星形细胞mRNA并逆转录获得eDNA,RT-PCR法测定GLP-1受体mR.NA的表达,免疫印迹法测定GLP-1受体蛋白的表达情况。结果显微镜下可以观察到活化的肝星形细胞为扁平状,胞体大,具有发育良好的应力纤维,胞浆内缺乏脂肪滴。GLP-1受体eDNA片段长度为296bp,与GenBank公布的人GLP-1受体eDNA序列(NM.002062.3)相符度为100%。免疫印迹法表明人肝星形细胞样本GLP-1受体蛋白表达阳性。结论人肝星形细胞上存在GLP-1受体的表达。 Objective To confirm the expression of glucagon-like peptide 1(GLP-1) receptor in human hepatic stellate cell (HSC). Methods Human HSC was cultured in vitro and morphologically identified. The mRNA of HSC was extracted and reversely transcribed to obtain cDNA. The mRNA of GLP-1 receptor was determined by RT-PCR. The GLP- 1 receptor protein was determined by western blotting. Results The activating HSC were flat, with large cell body and well-developed stress fibers and without fat droplets in the cytoplasm under the microscope. The length of GLP-1 receptor cDNA fragment was 296 bp, which was 100% consistent with the human GLP-1 receptor cDNA sequence (NM- 002062.3) published in Gen Bank. The results of western blotting showed that there was GLP- 1 receptor protein expressed in human HSC. Conclusions The GLP-1 receptor express in human HSC.
出处 《国际流行病学传染病学杂志》 CAS 2013年第4期236-238,F0003,共4页 International Journal of Epidemiology and Infectious Disease
基金 浙江省医药卫生科技计划(2013KYA144)
关键词 肝星形细胞 GLP-1受体 免疫印迹 RT-PCR 抗肝纤维化 Hpatic stellate cell GLP-1 receptor Western bloting RT-PCR Anti-hepatic fibrosis
  • 相关文献

参考文献12

  • 1Monji A, Mitsui T, Bando YK, et al. Glucagon-like peptide-1 recep- tor activation reverses cardiac remodeling via normalizing cardiac steatesis and oxidative stress in type 2 diabetes [J/OL]. Am J Physiol Heart Circ Physiol, 2013 [2013-05-01 ]. http://www, ncbi. nlm. nih. gov/pubmed/23709595. [ published online ahead of print May 24. 2013].
  • 2Loekie SH. llae GLP-1 receptor in the brain: role in neuroendoerine control of energy metabolism and treaunent target for obesity. J Neu- roandoerinol,2013, 25(7) :597-604.
  • 3Gupta NA, Mells J, Dunham RM,et al. Glucagon-like peptide-1 recep- tor is present on human hepatocytes and has a direct role in decreasing hepatic steatesis in vitro by modulating dements of the insulin signal- ing pathway. Hepatology, 2010,51(5) :1584-1592.
  • 4Gier B,Butler PC,Lai CK,et al. Glucagon like peptide-I receptor ex- pressian in the human thyroid gland. J Clin Endocrinol Metah, 2012, 97(1) : 121-131.
  • 5Park CW, Kim HW, Ko SH, et al. Long-term treatment of glucagon- like peptide-1 analogexendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. J Am Soc Nephrol,2007, 18(4) : 1227-1238.
  • 6Hillman M, Eriksson L, Mared L, et al. Reduced levels of active GLP-I in patients with cystic fibrosis with and without diabetes melli- tus.J Cyst Fibres,2012, II(2) : 144-149.
  • 7汤秀英,王昱,郭晓蕙,王书合,柴立军,张烨.胰高血糖素样多肽-1对OLETF大鼠肺泡毛细血管基板的影响[J].北京大学学报(医学版),2008,40(2):178-180. 被引量:9
  • 8Park CW, Kim HW, Ko SH, et al. Long-term treatment of glucagon-like pepfide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. J Am Soc Nephrol, 2007, 18(4) : 1227-1238.
  • 9张宏,姜丽娟,孙蓓,等.TGF-B1/Smad信号转导通路在OLEIF大鼠肺细胞外基质改变中的作用及GLP-1干预效应的研究.中华医学会第十次全国内分泌学学术会议论文汇编,苏州,2011.北京:中华医学会杂志社,2011.
  • 10Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology, 2008, EM(6) : 1655-1669.

二级参考文献8

  • 1王昱,郭晓蕙.胰升糖素样多肽-1对OLETF大鼠胰腺的保护作用[J].北京大学学报(医学版),2006,38(4):375-380. 被引量:7
  • 2申洪,等. 实用生物体视学技术[M]. 广州:中山大学出版, 1990.205-206.
  • 3郑富盛.细胞形态立体计量学[M].北京:北京医科大学出版社,1989.
  • 4Kawano K,Hirashima T,Mori S,et al.Spontaneous long-termhyperglycemic rat with diabetic complications Otsuka Long-Evans Tokushima Fatty (OLETF) strain[J].Diabetes,1992,41:1422-1428.
  • 5Carlson EC,Audette JL,Veitenheimer NJ,et al.Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice[J].Anat Rec,2003,271A:332-341.
  • 6Weyrand B,Jonchneere A,Fraus A,et al.Diabetes mellitus induces a thickening of the pulmonary basal lamina[J].Respiration,1999,66:14-19.
  • 7Mousa K,Onadeko BO,Mustafa HT,et al.Technetium 99mTc-DTPA clearance in the evaluation of pulmonary involvement in patients with diabetes mellitus[J].Respir Med,2000,94:1053-1056.
  • 8Buteau J,Foisy S,Joly E,et al.Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor[J].Diabetes,2003,52:124-132.

共引文献8

同被引文献14

  • 1李春霞,戴立里.肝星状细胞与肝纤维化研究进展[J].国际消化病杂志,2007,27(2):108-110. 被引量:16
  • 2Lockie SH. Glucagon-like peptide-1 receptor in the brain: role in neuroendoerine control of energy metabolism and treatment target for obesity[J]. J Neuroendocrinol, 2013, 25(7): 597-604.
  • 3Gupta NA, Mells J, Duaham RM, et al. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role indecreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway[J]. Hepatology, 201 O, 51 (5): 1584-1592.
  • 4Park CW, Kim HW, Ko SH, et al. Long-term treatment of glucagon- like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice[J]. J Am Soc Nephrol, 2007, 18(4): 1227-1238.
  • 5HiUman M, Eriksson L, Mared L, et al. Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus[J]. J Cyst Fibros, 2012, 11(2): 144-149.
  • 6Friedman SL. Mechanisms of hepatic fibrogenesis[J]. Gastroenterology, 2008, 134(6): 1655-1669.
  • 7Friedman SL. Hepatic steUate cells: protean, mulfifunctional, and enigmatic cells of the liver[J]. Physiol Rev, 2008, 88(1): 125-172.
  • 8De Minieis S, Seki E, Uchinami H, et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo[J]. Gaslroenterology, 2007, 132(5): 1937-1946.
  • 9Brown MD, Sacks DB. Compartmentalised MAPK pathways[J]. Handb Exp Pharmacol, 2008, (186): 205-235.
  • 10Kyriakis JM, Avruch. J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update[J]. Physiol Rev, 2012, 92(2): 689-737.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部